Transcription of Nrdp1 by the androgen receptor is regulated by nuclear filamin A in prostate cancer

Rosalinda M. Savoy, Liqun Chen, Salma Siddiqui, Frank U. Melgoza, Blythe Durbin-Johnson, Christiana Drake, Maitreyee K. Jathal, Swagata Bose, Thomas M. Steele, Benjamin A. Mooso, Leandro S. D'Abronzo, William H. Fry, Kermit L Carraway, Maria Mudryj, Paramita M Ghosh

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Prostate cancer (PCa) progression is regulated by the androgen receptor (AR); however, patients undergoing androgen-deprivation therapy (ADT) for disseminated PCa eventually develop castration-resistant PCa (CRPC). Results of previous studies indicated that AR, a transcription factor, occupies distinct genomic loci in CRPC compared with hormone-naïve PCa; however, the cause of this distinction was unknown. The E3 ubiquitin ligase Nrdp1 is a model AR target modulated by androgens in hormone-naïve PCa but not in CRPC. Using Nrdp1, we investigated how AR switches transcription programs during CRPC progression. The proximal Nrdp1 promoter contains an androgen response element (ARE); we demonstrated AR binding to this ARE in androgen-sensitive PCa. Analysis of hormone-naive human prostatectomy specimens revealed correlation between Nrdp1 and AR expression, supporting AR regulation of NRDP1 levels in androgen-sensitive tissue. However, despite sustained AR levels, AR binding to the Nrdp1 promoter and Nrdp1 expression were suppressed in CRPC. Elucidation of the suppression mechanism demonstrated correlation of NRDP1 levels with nuclear localization of the scaffolding protein filamin A (FLNA) which, as we previously showed, is itself repressed following ADT in many CRPC tumors. Restoration of nuclear FLNA in CRPC stimulated AR binding to Nrdp1 ARE, increased its transcription, and augmented NRDP1 protein expression and responsiveness to ADT, indicating that nuclear FLNA controls AR-mediated androgen-sensitive Nrdp1 transcription. Expression of other AR-regulated genes lost in CRPC was also re-established by nuclear FLNA. Thus, our results indicate that nuclear FLNA promotes androgen-dependent AR-regulated transcription in PCa, while loss of nuclear FLNA in CRPC alters the AR-regulated transcription program.

Original languageEnglish (US)
Pages (from-to)369-386
Number of pages18
JournalEndocrine-Related Cancer
Volume22
Issue number3
DOIs
StatePublished - Jun 1 2015

Fingerprint

Filamins
Androgen Receptors
Prostatic Neoplasms
Castration
Androgens
Response Elements
Hormones
Ubiquitin-Protein Ligases
Prostatectomy

Keywords

  • ABP280/filamin A
  • AR/androgen receptor
  • Castration-resistant prostate cancer
  • FLRF/RNF41/Nrdp1
  • HER3/ErbB3

ASJC Scopus subject areas

  • Endocrinology
  • Oncology
  • Cancer Research
  • Endocrinology, Diabetes and Metabolism

Cite this

Transcription of Nrdp1 by the androgen receptor is regulated by nuclear filamin A in prostate cancer. / Savoy, Rosalinda M.; Chen, Liqun; Siddiqui, Salma; Melgoza, Frank U.; Durbin-Johnson, Blythe; Drake, Christiana; Jathal, Maitreyee K.; Bose, Swagata; Steele, Thomas M.; Mooso, Benjamin A.; D'Abronzo, Leandro S.; Fry, William H.; Carraway, Kermit L; Mudryj, Maria; Ghosh, Paramita M.

In: Endocrine-Related Cancer, Vol. 22, No. 3, 01.06.2015, p. 369-386.

Research output: Contribution to journalArticle

Savoy, RM, Chen, L, Siddiqui, S, Melgoza, FU, Durbin-Johnson, B, Drake, C, Jathal, MK, Bose, S, Steele, TM, Mooso, BA, D'Abronzo, LS, Fry, WH, Carraway, KL, Mudryj, M & Ghosh, PM 2015, 'Transcription of Nrdp1 by the androgen receptor is regulated by nuclear filamin A in prostate cancer', Endocrine-Related Cancer, vol. 22, no. 3, pp. 369-386. https://doi.org/10.1530/ERC-15-0021
Savoy, Rosalinda M. ; Chen, Liqun ; Siddiqui, Salma ; Melgoza, Frank U. ; Durbin-Johnson, Blythe ; Drake, Christiana ; Jathal, Maitreyee K. ; Bose, Swagata ; Steele, Thomas M. ; Mooso, Benjamin A. ; D'Abronzo, Leandro S. ; Fry, William H. ; Carraway, Kermit L ; Mudryj, Maria ; Ghosh, Paramita M. / Transcription of Nrdp1 by the androgen receptor is regulated by nuclear filamin A in prostate cancer. In: Endocrine-Related Cancer. 2015 ; Vol. 22, No. 3. pp. 369-386.
@article{5e0b7a8ea15d4dd381e17d7ab98e5e48,
title = "Transcription of Nrdp1 by the androgen receptor is regulated by nuclear filamin A in prostate cancer",
abstract = "Prostate cancer (PCa) progression is regulated by the androgen receptor (AR); however, patients undergoing androgen-deprivation therapy (ADT) for disseminated PCa eventually develop castration-resistant PCa (CRPC). Results of previous studies indicated that AR, a transcription factor, occupies distinct genomic loci in CRPC compared with hormone-na{\"i}ve PCa; however, the cause of this distinction was unknown. The E3 ubiquitin ligase Nrdp1 is a model AR target modulated by androgens in hormone-na{\"i}ve PCa but not in CRPC. Using Nrdp1, we investigated how AR switches transcription programs during CRPC progression. The proximal Nrdp1 promoter contains an androgen response element (ARE); we demonstrated AR binding to this ARE in androgen-sensitive PCa. Analysis of hormone-naive human prostatectomy specimens revealed correlation between Nrdp1 and AR expression, supporting AR regulation of NRDP1 levels in androgen-sensitive tissue. However, despite sustained AR levels, AR binding to the Nrdp1 promoter and Nrdp1 expression were suppressed in CRPC. Elucidation of the suppression mechanism demonstrated correlation of NRDP1 levels with nuclear localization of the scaffolding protein filamin A (FLNA) which, as we previously showed, is itself repressed following ADT in many CRPC tumors. Restoration of nuclear FLNA in CRPC stimulated AR binding to Nrdp1 ARE, increased its transcription, and augmented NRDP1 protein expression and responsiveness to ADT, indicating that nuclear FLNA controls AR-mediated androgen-sensitive Nrdp1 transcription. Expression of other AR-regulated genes lost in CRPC was also re-established by nuclear FLNA. Thus, our results indicate that nuclear FLNA promotes androgen-dependent AR-regulated transcription in PCa, while loss of nuclear FLNA in CRPC alters the AR-regulated transcription program.",
keywords = "ABP280/filamin A, AR/androgen receptor, Castration-resistant prostate cancer, FLRF/RNF41/Nrdp1, HER3/ErbB3",
author = "Savoy, {Rosalinda M.} and Liqun Chen and Salma Siddiqui and Melgoza, {Frank U.} and Blythe Durbin-Johnson and Christiana Drake and Jathal, {Maitreyee K.} and Swagata Bose and Steele, {Thomas M.} and Mooso, {Benjamin A.} and D'Abronzo, {Leandro S.} and Fry, {William H.} and Carraway, {Kermit L} and Maria Mudryj and Ghosh, {Paramita M}",
year = "2015",
month = "6",
day = "1",
doi = "10.1530/ERC-15-0021",
language = "English (US)",
volume = "22",
pages = "369--386",
journal = "Endocrine-Related Cancer",
issn = "1351-0088",
publisher = "Society for Endocrinology",
number = "3",

}

TY - JOUR

T1 - Transcription of Nrdp1 by the androgen receptor is regulated by nuclear filamin A in prostate cancer

AU - Savoy, Rosalinda M.

AU - Chen, Liqun

AU - Siddiqui, Salma

AU - Melgoza, Frank U.

AU - Durbin-Johnson, Blythe

AU - Drake, Christiana

AU - Jathal, Maitreyee K.

AU - Bose, Swagata

AU - Steele, Thomas M.

AU - Mooso, Benjamin A.

AU - D'Abronzo, Leandro S.

AU - Fry, William H.

AU - Carraway, Kermit L

AU - Mudryj, Maria

AU - Ghosh, Paramita M

PY - 2015/6/1

Y1 - 2015/6/1

N2 - Prostate cancer (PCa) progression is regulated by the androgen receptor (AR); however, patients undergoing androgen-deprivation therapy (ADT) for disseminated PCa eventually develop castration-resistant PCa (CRPC). Results of previous studies indicated that AR, a transcription factor, occupies distinct genomic loci in CRPC compared with hormone-naïve PCa; however, the cause of this distinction was unknown. The E3 ubiquitin ligase Nrdp1 is a model AR target modulated by androgens in hormone-naïve PCa but not in CRPC. Using Nrdp1, we investigated how AR switches transcription programs during CRPC progression. The proximal Nrdp1 promoter contains an androgen response element (ARE); we demonstrated AR binding to this ARE in androgen-sensitive PCa. Analysis of hormone-naive human prostatectomy specimens revealed correlation between Nrdp1 and AR expression, supporting AR regulation of NRDP1 levels in androgen-sensitive tissue. However, despite sustained AR levels, AR binding to the Nrdp1 promoter and Nrdp1 expression were suppressed in CRPC. Elucidation of the suppression mechanism demonstrated correlation of NRDP1 levels with nuclear localization of the scaffolding protein filamin A (FLNA) which, as we previously showed, is itself repressed following ADT in many CRPC tumors. Restoration of nuclear FLNA in CRPC stimulated AR binding to Nrdp1 ARE, increased its transcription, and augmented NRDP1 protein expression and responsiveness to ADT, indicating that nuclear FLNA controls AR-mediated androgen-sensitive Nrdp1 transcription. Expression of other AR-regulated genes lost in CRPC was also re-established by nuclear FLNA. Thus, our results indicate that nuclear FLNA promotes androgen-dependent AR-regulated transcription in PCa, while loss of nuclear FLNA in CRPC alters the AR-regulated transcription program.

AB - Prostate cancer (PCa) progression is regulated by the androgen receptor (AR); however, patients undergoing androgen-deprivation therapy (ADT) for disseminated PCa eventually develop castration-resistant PCa (CRPC). Results of previous studies indicated that AR, a transcription factor, occupies distinct genomic loci in CRPC compared with hormone-naïve PCa; however, the cause of this distinction was unknown. The E3 ubiquitin ligase Nrdp1 is a model AR target modulated by androgens in hormone-naïve PCa but not in CRPC. Using Nrdp1, we investigated how AR switches transcription programs during CRPC progression. The proximal Nrdp1 promoter contains an androgen response element (ARE); we demonstrated AR binding to this ARE in androgen-sensitive PCa. Analysis of hormone-naive human prostatectomy specimens revealed correlation between Nrdp1 and AR expression, supporting AR regulation of NRDP1 levels in androgen-sensitive tissue. However, despite sustained AR levels, AR binding to the Nrdp1 promoter and Nrdp1 expression were suppressed in CRPC. Elucidation of the suppression mechanism demonstrated correlation of NRDP1 levels with nuclear localization of the scaffolding protein filamin A (FLNA) which, as we previously showed, is itself repressed following ADT in many CRPC tumors. Restoration of nuclear FLNA in CRPC stimulated AR binding to Nrdp1 ARE, increased its transcription, and augmented NRDP1 protein expression and responsiveness to ADT, indicating that nuclear FLNA controls AR-mediated androgen-sensitive Nrdp1 transcription. Expression of other AR-regulated genes lost in CRPC was also re-established by nuclear FLNA. Thus, our results indicate that nuclear FLNA promotes androgen-dependent AR-regulated transcription in PCa, while loss of nuclear FLNA in CRPC alters the AR-regulated transcription program.

KW - ABP280/filamin A

KW - AR/androgen receptor

KW - Castration-resistant prostate cancer

KW - FLRF/RNF41/Nrdp1

KW - HER3/ErbB3

UR - http://www.scopus.com/inward/record.url?scp=84937035794&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937035794&partnerID=8YFLogxK

U2 - 10.1530/ERC-15-0021

DO - 10.1530/ERC-15-0021

M3 - Article

C2 - 25759396

AN - SCOPUS:84937035794

VL - 22

SP - 369

EP - 386

JO - Endocrine-Related Cancer

JF - Endocrine-Related Cancer

SN - 1351-0088

IS - 3

ER -